Most authorities (Talbott and Terplan, 1969; Stanbury, Wijngaarden, and Fredrickson, 1966) consider gout to be a primary inherited metabolic disorder. It is often associated with an ill defined form of 'degenerative' renal disease, probably secondary in nature, which is slowly progressive (Gutman and Yu, 1957) and may eventually lead to death through renal failure. Opinions on the frequency of this event differ from 10 to 25% in various reports (Gonick, Rubini, Gleason, and Sommers, 1965; Heptinstall, 1966; Talbott and Terplan, 1960) . On the other hand, any type of renal failure will eventually lead to hyperuricaemia but clinical gout secondary to renal disease is rare (Merrill, 1955;  Richet, Mignon, and Ardaillou, 1965; Heptinstall, 1966) .
In this paper a family is described in which fatal renal disease, and in many cases hypertension, occurred, together with hyperuricaemia and gout. The particular gravity of the renal disease, overshadowing the manifestations of gout as well as the anatomical lesion, distinguished these patients from those with classical 'gouty nephropathy'. The possibility that they represent a hitherto not clearly defined disease entity should therefore be considered.
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Methods
Creatinine concentrations were measured by the AutoAnalyzer technique. Creatinine clearances were calculated from 24-hour urine specimens. Uric acid in blood and urine was determined by the method of Caraway (1955) . Concentration tests were performed by 20 hours of fluid restriction.
The Family
Five generations were investigated, consisting of 71 direct descendants. Twenty-five relatives by marriage were also studied. Of these 97 persons, 67 were examined personally by one ofus; 24 ofthe remaining 29 were dead at the time of the study but adequate information on the illness and cause of death was collected by interviewing acquaintances and family doctors as well as from medical records. Five children were not examined. Among the relatives by marriage, three probably had been suffering from hypertension; none showed signs of renal disease, gout, or 'related' illnesses (diabetes, obesity, arteriosclerosis). Consanguinity was not found to be present or likely to be present in any of the marriages. Figure 1 shows that in the grandfather and his direct descendants hyperuricaemia, gout, renal disease, and hypertension frequently occurred simultaneously. (Table III) . The first patient we investigated was a man of 37 years (propositus, III, 25) who had suffered a single attack of podagra two years before. His mentioning a 'family ailment' initiated the present investigation. He presented with incipient renal failure and complaints of general discomfort and 'convulsions'. At that time a renal biopsy was performed. He was followed up until his death four years later. With conservative treatment, including uricosurics, he remained well for three years without attacks of gout. During the last months of his life he suffered from severe sciatic pains and pain in the shoulders caused by uraemic osteodystrophy.
In five young relatives hyperuricaemia was found; only one of them (III, 27) had suffered from attacks of podagra since the age of 20. All had a markedly diminished renal concentrating power. Three had some degree of hypertension and decreased creatinine clearances. None of them secreted more than normal amounts of uric acid (Table III) Renal biopsies were performed in four of the patients. The biopsies from the three patients (IV, 25, IV, 27, IV, 29) who had only slight renal functional impairment showed a largely identical picture. The biopsy material consisted mainly of medullary tissue and contained only a small number of glomeruli. In two biopsies (IV, 25 and IV, 29) some glomeruli were hyalinized; the other biopsies showed either no significant glomerular lesions or a doubtful increase in mesangial fibres (IV, 27) . In IV, 27 and IV, 29 capsular basement membranes were thickened and there was tubular atrophy; in IV, 25 many tubules were dilated. In all three biopsies there were tubules containing protein casts, and brown, granular intracellular pigment, presumably lipofuchsin. Some tubules were surrounded by a thickened basement membrane (Fig. 2) The necropsy on this patient revealed kidneys weighing 120 and 127 g; the calyces were widened and contained some small concrements. Microscopically the main impression was that of an atrophic kidney, with sparsely interspersed hypertrophic glomeruli and tubules (Fig. 3) Such predominance of fatal renal disease in a gout family is very unusual and to our knowledge has been reported only once (Duncan and Dixon, 1960) . As can be seen in Tables I and II , all the six patients suffering from gout had also renal disease. In six other patients renal disease was present without manifestations of gout. This raises the question whether the renal disease was the primary event which might have caused secondary gout.
The urinary uric acid excretion was found to be either normal or low (Table III) . Although in patients with renal impairment a greater proportion of uric acid is disposed by extrarenal routes (Sorensen, 1962) , these figures do not suggest that our patients' uric acid was produced in significantly excessive amounts. According to Sorensen (1962) , about 40% (or 200 mg per day) of the uric acid normally excreted in the urine leaves the body by intestinal uricolysis. This amount is proportionately greater with higher serum concentrations. If this were taken into account in our patients, total production would not exceed the upper limits, which are given as 700 to 900 mg per day.
In our introduction we referred to the fact that gout is considered to be infrequent in primary renal disease, but on this point opinions differ greatly. Richet, Ardaillou, Montera, Slama, and Bougault (1961) reported 17 cases of gout in 1,600 unselected patients predominantly with renal disease. Among these 17 patients were some with amyloid. Sarre and Mertz (1965) found only two cases that were considered to have secondary gout out of 342 patients with renal disease and nitrogen retention. Talbott and Terplan (1960) are of the opinion that the evidence in favour of secondary gout is inconclusive, whereas convincing evidence of renal insufficiency as a complication of gout 'questions the supposition that any acute articular distress in a patient with increased uric acid concentration in the blood be due to renal disease'. Wijngaarden (in Stanbury et al, 1966 ) also favours the view that all renal disease in cases of gout may be secondary.
Descriptions in the literature of the renal lesion in gout are not identical. Talbott and Terplan (1960) consider pyelonephritis or at least interstitial infiltrates to be the most important lesion, and urate deposits the most characteristic feature. However, in a few patients they noted a variety of renal abnormalities, including benign and malignant arteriosclerosis and amyloid deposition, which they regarded as secondary features. They also found a definite correlation between the clinical severity of the arthritis and the renal lesions, but again with notable exceptions. Richet et al (1961) noticed frequent signs of pyelonephritis secondary to uric acid lithiasis, but found no argument for a glomerular lesion. Authors studying the earlier stages of the disease by biopsy arrived at different conclusions. Barlow and Beilin (1968) stressed the occurrence of vascular sclerosis and Gonick et al (1965) found degeneration of cells of Henle's loops, together with fibrillar thickening of the glomerular basement membrane and vascular sclerosis, which they regard as specific and preceding functional impairment, a view not shared by others (Heptinstall, 1966; Barlow and Bellin, 1968) . Greenbaum, Ross, and Steinberg (1961) and Louyot and Gaucher (1961) , in biopsy studies of patients with gout, reported a variety of 'degenerative' lesions, including vascular sclerosis, glomerular hyalinization, tubular atrophy, and interstitial fibrosis. Uric acid deposits were found only occasionally. Zollinger (1966) and Heptinstall (1966) found no convincing evidence of a specific renal lesion resulting from gout. In addition, Heptinstall (1966) cites a patient in whom gout unquestionably arose after longstanding renal disease. He also regards the presence of uric acid crystals as the only specific sign. Even this has been challenged, however, since Verger, Leroux-Robert, Ganter, and Richet (1967) not infrequently demonstrated typical tophi with surrounding necrosis in kidneys from patients with primary renal diseases.
It is clear that the picture in all the patients we examined differs markedly from the above descriptions. The absence of uric acid deposits, even in the necropsy material, casts some doubt on the diagnosis of 'gout kidney'. Chronic lead poisoning is also a condition in which nephropathy and gout occur together. The renal lesion, apart from the intranuclear inclusions, is considered equally nonspecific. One description (Morgan, Marshall, Hartley, and Miller, 1966) also mentions the occurrence of peritubular basement membrane thickening. In this condition the uric acid clearance values are relatively more diminished in relation to the glomerular filtration rate than in other types of renal disease, and the gout may well be secondary to the renal lesion.
The thickening of the tubular basement membrane presents an unusual feature. In itself it is not a specific sign. It has been described as a prominent feature in some inherited chronic degenerative disorders of unknown aetiology, eg, juvenile nephronopthisis (Ivemark, Ljungqvist, and Barty, 1960) , the kidney disease associated with retinitis pigmentosa (Meier and Hess, 1965) , and renal ischaemia from arterial occlusion (Barajas, Lupu, Kaufman, Latta, and Maxwell, 1967) , and in the so-called phenacetin kidney'.
In conclusion, we assume that our patients suffered from a hereditary disorder which caused kidney damage, hypertension, and hyperuricaemia and differs clinically and pathologically from that seen in classical gout. It may therefore constitute a separate entity. The possibility that the renal disease is not a direct consequence of the hyperuricaemia should be seriously considered.
